First-in-Human Study of CLS003 ICVT in Subjects With Cutaneous Warts

Exclusion Criteria

• •For women, a positive pregnancy test and/or nursing at screening
• •A positive test for drugs of abuse at screening
• •History of alcohol or illicit drug abuse
• •Positive test results for Hepatitis B, Hepatitis C or HIV
• •Have used salicylic acid or any other over-the-counter- wart-removing product in the treatment area within 30 days prior to enrollment
• •Have received cryotherapy in the treatment area within 60 days prior to enrollment
• •Have required systemic intake of immunosuppressive or immunomodulatory medication (including oral or parenteral corticosteroids) with 30 days prior to enrollment or during the course of the study.